PRMT5 has been increasingly associated with maintaining normal cell and leukemic cell “stemness” (Jin et al., 2016, Liu et al., 2015, Tee et al., 2010, Zhang et al., 2015), but very little is known about the role of PRMT5 in cancer stem cells driving carcinoma formation. This evidence concerns the gene PRMT5 and carcinoma.